Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy

BMC Research Notes

N R Jagannathan³  R M Pandey²  Raghunandan P¹  Uma Sharma³  Meera Ekka¹  Sanjeev Sinha¹ 

[1] Department of Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India;Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India;Department of NMR & MRI Facility, All India Institute of Medical Sciences, New Delhi, India

关键词: MR Spectroscopy;    Brain metabolites;    Diabetes mellitus;   

Others  :  1134778
DOI  :  10.1186/1756-0500-7-41

 received in 2013-08-07, accepted in 2014-01-10,  发布年份 2014

【 摘 要 】

Background

The brain is a target for diabetic end-organ damage, though the pathophysiology of diabetic encephalopathy is still not well understood. The aim of the present study was to investigate the effect of diabetes on the metabolic profile of brain of patients having diabetes in comparison to healthy controls, using in-vivo magnetic resonance spectroscopy to get an insight into the pathophysiology of cerebral damages caused due to diabetes.

Methods

Single voxel proton magnetic resonance spectroscopy (¹H-MRS) was performed at 1.5 T on right frontal, right parieto-temporal and right parieto-occipital white matter regions of the brain of 10 patients having type-2 diabetes along with 7 healthy controls. Absolute concentration of N-acetylaspartate (NAA), choline (cho), myo-inositol (mI), glutamate (Glu) and glutamine (Gln), creatine (Cr) and glucose were determined using the LC-Model and compared between the two groups.

Results

The concentration of N-acetylaspartate was significantly lower in the right frontal [4.35 ±0.69 vs. 5.23 ±0.74; p = 0.03] and right parieto-occipital region [5.44 ±0.52 vs.6.08 ±0.25; p = 0.02] of the brain of diabetics as compared to the control group. The concentrations of glutamate and glutamine were found to be significantly higher in the right frontal region of the brain [7.98 ±2.57 vs. 5.32 ±1.43; P = 0.01] in diabetics. Glucose levels were found significantly elevated in all the three regions of the brain in diabetics as compared to the control group. However, no significant changes in levels of choline, myo-inositol and creatine were observed in the three regions of the brain examined among the two groups.

Conclusions

¹H-MRS analysis indicates that type-2 diabetes mellitus may cause subtle changes in the metabolic profile of the brain. Decreased concentrations of NAA might be indicative of decreased neuronal viability in diabetics while elevated concentrations of Gln and Glu might be related to the fluid imbalance resulting from disruption of glucose homeostasis.

【 授权许可】

   
2014 Sinha et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]IDF Diabetes Atlas Update. 2012. http://www.idf.org/sites/default/files/5E_IDFAtlasPoster_2012_EN.pdf webcite
• [2]Gispen WH, Biessels GJ: Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 2000, 23:542-549.
• [3]Arvanitakis Z, Wilson RS, Li Y, Aggarwal NT, Bennett DA: Diabetes and function in different cognitive systems in older individuals without dementia. Dia Care 2006, 29:560-565.
• [4]Ajilore O, Haroon E, Kumaran S, Darwin C, Binesh N, Mintz J, Miller J, Thomas MA, Kumar A: Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropsychopharmacology 2006, 32:1224-1231.
• [5]Biessels GJ, van der Heide LP, Kamal A, Bleys RLAW, Gispen WH: Ageing and diabetes: implications for brain function. Eur J Pharmacol 2002, 441:1-14.
• [6]Yau PL, Javier DC, Ryan CM, Tsui WH, Ardekani BA, Ten S, Convit A: Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia 2010, 53:2298-2306.
• [7]Van Harten B, De Leeuw F-E, Weinstein HC, Scheltens P, Biessels GJ: Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006, 29:2539-2548.
• [8]Ross B, Bluml S: Magnetic resonance spectroscopy of the human brain. Anat Rec 2001, 265:54-84.
• [9]Ross B, Michaelis T: Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994, 10:191-247.
• [10]Hsu Y-Y, Chang C, Chang C-N, Chu N-S, Lim K-E, Hsu J-C: Proton MR spectroscopy in patients with complex partial seizures: single-voxel spectroscopy versus chemical-shift imaging. Am J Neuroradiol 1999, 20:643-651.
• [11]Parnetti L, Tarducci R, Presciutti O, Lowenthal DT, Pippi M, Palumbo B, Gobbi G, Pelliccioli GP, Senin U: Proton magnetic resonance spectroscopy can differentiate Alzheimer’s disease from normal aging. Mech Ageing Dev 1997, 97:9-14.
• [12]Sinha S, Kumar V, Jagannathan NR, Pandey RM: Proton magnetic resonance spectroscopy of brain to study the cerebral metabolic abnormalities in COPD patients: a case control study in north India. Indian J Chest Dis Allied Sci 2009, 51:15-19.
• [13]Sharma SK, Sinha S, Danishad KA, Sharma U, Sharma H, Mishra HK, Mishra H, Kadhiravan T, Reddy VV, Sreenivas V, Jagannathan NR: Proton magnetic resonance spectroscopy of brain in obstructive sleep apnoea in north Indian Asian subjects. Indian J Med Res 2010, 132:278-286.
• [14]Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
• [15]Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
• [16]American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl 1):S62-S69.
• [17]Sahin I, Alkan A, Keskin L, Cikim A, Karakas HM, Firat AK, Sigirci A: Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Diabetes Complications 2008, 22:254-260.
• [18]Burtscher IM, Holtås S: Proton MR spectroscopy in clinical routine. J Magn Reson Imaging 2001, 13:560-567.
• [19]Mäkimattila S, Malmberg-Cèder K, Häkkinen A-M, Vuori K, Salonen O, Summanen P, Yki-Järvinen H, Kaste M, Heikkinen S, Lundbom N, Roine RO: Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury. J Int Soc Cereb Blood Flow Metab 2004, 24:1393-1399.
• [20]Katsura K, Folbergrová J, Siesjö BK: Changes in labile energy metabolites, redox state and intracellular pH in postischemic brain of normo- and hyperglycemic rats. Brain Res 1996, 726:57-63.
• [21]Muranyi M, Fujioka M, He Q, Han A, Yong G, Csiszar K, Li P-A: Diabetes activates cell death pathway after transient focal cerebral ischemia. Diabetes 2003, 52:481-486.
• [22]Tiehuis A, van der Meer F, Mali W, Pleizier M, Biessels GJ, Kappelle J, Luijten P: MR spectroscopy of cerebral white matter in type 2 diabetes; no association with clinical variables and cognitive performance. Neuroradiology 2010, 52:155-161.
• [23]Kreis R, Ross BD: Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 1992, 184:123-130.
• [24]Castillo M, Smith JK, Kwock L: Correlation of myo-inositol levels and grading of cerebral astrocytomas. Am J Neuroradiol 2000, 21:1645-1649.
• [25]Schweinsburg BC, Taylor MJ, Videen JS, Alhassoon OM, Patterson TL, Grant I: Elevated myo-inositol in gray matter of recently detoxified but not long-term abstinent alcoholics: a preliminary MR spectroscopy study. Alcohol Clin Exp Res 2000, 24:699-705.
• [26]Constans JM, Meyerhoff DJ, Gerson J, MacKay S, Norman D, Fein G, Weiner MW: H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia. Radiology 1995, 197:517-523.
• [27]Sajjad Z, Alam S: Magnetic resonance spectroscopy (MRS): basic principles and applications in focal brain lesions. Pak J Neurol Sci 2007, 2:42-46.
• [28]Brand A, Richter-Landsberg C, Leibfritz D: Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993, 15:289-298.
• [29]De Graaf RA, Pan JW, Telang F, Lee JH, Brown P, Novotny EJ, Hetherington HP, Rothman DL: Differentiation of glucose transport in human brain gray and white matter. J Int Soc Cereb Blood Flow Metab 2001, 21:483-492.
• [30]Van de Ven KCC, van der Graaf M, Tack CJ, Heerschap A, De Galan BE: Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes. Diabetes 2012, 61:1974-1977.